Treatment of Major Depressive Disorder

First-Line Treatment Options

• Either cognitive behavioral therapy (CBT) or a second-generation antidepressant (SGA) such as an SSRI is an appropriate first-line treatment for major depressive disorder, with the choice depending on patient preference and symptom severity, as recommended by the American College of Physicians (ACP) with moderate-quality evidence 1
• SSRIs, such as Fluoxetine and Paroxetine, are commonly used as first-line treatments due to their favorable side effect profile compared to older antidepressants, with initial doses of 20 mg once daily 1
• The ACP guidelines provide moderate-quality evidence showing no significant difference in response rates between SGAs and cognitive behavioral therapy for the treatment of MDD 1

Psychotherapy Options

• Cognitive behavioral therapy (CBT) has shown equal effectiveness to SGAs with fewer adverse effects, and is the most evidence-based option for psychotherapy, as recommended by the American College of Physicians and the American Psychological Association 1, 2, 3, 4
• Other effective psychotherapies include Interpersonal therapy and Psychodynamic therapies, as noted by the American Psychological Association 1, 5
• Individual cognitive behavioral therapy (CBT) has strong evidence for anxiety disorders, with structured CBT sessions (approximately 14 sessions over 4 months) being a recommended approach, as suggested by the American Psychological Association 6
• Self-help with CBT support is also an option if face-to-face therapy is not feasible, according to the American Psychological Association 6

Medication Dosage and Administration

• The typical effective dose range for bupropion is 50-200 mg daily, according to the American Academy of Family Physicians, with an initial dose of 25-50 mg once daily 7
• Buspirone is recommended as a first-line adjunct medication for patients taking bupropion who need additional treatment for anxiety, with an initial dose of 5mg twice daily, which can be increased up to a maximum of 20mg three times daily, as recommended by the American Academy of Family Physicians 7
• The following medications have specific dosing recommendations:

• Older adults should start with lower doses of SSRIs, such as sertraline or escitalopram, according to the American College of Physicians, while patients with cardiovascular disease should start with lower doses of sertraline (25mg daily) and titrate slowly 8
• Patients with substance use histories should avoid benzodiazepines and consider alternative treatments like buspirone, as advised by the American Academy of Child and Adolescent Psychiatry and the American Academy of Family Physicians 7, 9

Special Populations

• Patients with bipolar depression should avoid antidepressant monotherapy and consult with psychiatry for mood stabilizer options, as recommended by the American Urological Association 10
• Patients with chronic pain should consider duloxetine as a first-line option, according to the American College of Physicians 8
• Patients with systemic lupus erythematosus (SLE) should be monitored for disease flares and ensure optimal control of underlying medical conditions, as recommended by the American College of Physicians 8

Treatment Duration and Monitoring

• Treatment should continue for at least 4-9 months after remission to prevent relapse, as recommended by the American College of Physicians 1
• Regular assessment of treatment effectiveness using standardized scales, such as the GAD-7 scale, is necessary to monitor progress, with scores ranging from 0-4 (mild anxiety), 5-9 (moderate anxiety), and 10-21 (moderate to severe anxiety), as recommended by the American College of Physicians and the American Psychological Association 11, 4

• Regular monitoring of blood pressure is advisable, especially at higher doses, due to the potential for cardiac conduction abnormalities and blood pressure increases, as reported by the Mayo Clinic Proceedings 12
• Dosage reduction is required in patients with renal insufficiency, according to the Mayo Clinic Proceedings 12

Augmentation Strategies

• Adding bupropion to existing SSRI is a recommended augmentation strategy, with moderate evidence showing it can be more effective than buspirone augmentation for depression, as noted by the American College of Physicians 1
• Concurrent cognitive behavioral therapy (CBT) is recommended, which has shown effectiveness for anxiety disorders, according to the Japanese Society of Anxiety and Related Disorders guidelines 6